A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)
The use of a simplified treatment regimen by oncologists, along with management recommendations and 24/7 support provided by a limited ...